Today: 9 June 2026
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point
9 June 2026

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
Read More
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Read More
T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

···
9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
Read More
IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

IREN surged 9% to $59.19 as investors returned to crypto and AI infrastructure stocks after last week’s selloff, driven by a $3.65 billion investment-grade GPU financing to support its Microsoft AI cloud contract and news of a planned 800MW data-center in Australia, but future gains hinge on execution, contract delivery, and bitcoin price stability.
8 June 2026
········
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas shares slipped 0.5% to $10.38 as investors weighed a new $4.8M U.S. Navy-linked balloon contract and $110M in Q2 orders against high short interest (31.33% of float), rising operating losses, and fresh stock-supply concerns after a June 3 filing revealed more Omnisys-related shares could hit the market, raising dilution risks despite surging revenue and backlog.
8 June 2026
···

Redwire Shares Sink Despite Space Strawberry News

Redwire Shares Sink Despite Space Strawberry News

······
7 June 2026
Redwire Corp. plunged 25% this week, closing at $18.45 after Jefferies cut its rating to Hold, citing “limited near-term upside” despite a raised price target; trading was volatile following a new space-agriculture contract and amid a broad selloff in speculative space stocks as investors question if recent contract wins can support the stock’s run ahead of earnings.
Read More
June 2025 AI News Roundup: Breakthroughs, Surprises, and Global Developments

June 2025 AI News Roundup: Breakthroughs, Surprises, and Global Developments

······
28 June 2025
OpenAI CEO Sam Altman said GPT-5 will launch in summer 2025, claiming major improvements over GPT-4. Midjourney released its first text-to-video system, Model V1, in June 2025. Meta delayed LLaMA 4 Behemoth to late 2025 due to performance issues. Google DeepMind introduced Gemini Robotics On-Device, running vision-language-action AI entirely on robots.
Read More

Latest

Chip Selloff Trips Up Wall Street’s AI Rally

Chip Selloff Trips Up Wall Street’s AI Rally

Nasdaq and S&P 500 tumbled midday, erasing early chip-stock gains as tech shares slid; Philadelphia Semiconductor Index dropped 2% after jumping 3%, with Broadcom, Micron, and Nvidia under pressure. Investors await key inflation data Wednesday and SpaceX’s massive IPO, both seen as catalysts for further volatility amid concerns that high valuations in AI and tech could face profit-taking if rate fears persist.
·····
09 Jun
Nintendo and Sanrio Stocks Get New AI Boost

Nintendo and Sanrio Stocks Get New AI Boost

Nintendo hikes Switch 2 prices in Japan and the US, citing higher memory costs and tariffs expected to add 100 billion yen to annual expenses; investors now question whether Japan’s top entertainment brands like Nintendo and Sanrio can maintain valuations as AI-driven capital shifts toward chips and automation, pressuring stock selection even as the Nikkei rebounds 2.17% after Monday’s sharp drop.
····
09 Jun
Costco Drops Kirkland Prices While Prepping New Florida Warehouse

Costco Drops Kirkland Prices While Prepping New Florida Warehouse

Costco slashed prices on select Kirkland Signature products by up to $10 as part of its strategy to boost membership renewals, but shares barely moved, last at $973.50, down $1.25, after Q3 net sales rose 11.6% to $69.15 billion and net income hit $2.19 billion; management emphasized the cuts are strategic, not a chainwide rollback, amid slowing paid membership growth and ongoing competitive pressure.
·
09 Jun
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
·
09 Jun
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
···
09 Jun
Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Global soared 158.75% to $1.33 before a Nasdaq volatility pause, putting the stock above the $1 minimum bid-price needed for compliance after months below the threshold; the company must now close at or above $1 for 10 straight business days to avoid further Nasdaq action, with no new company news driving the surge.
·
09 Jun
Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
·
09 Jun
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
··
09 Jun
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
·
09 Jun
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
···
09 Jun
Go toTop